Relevance of plasma level determination of L-dopa and 3-O-methyldopa in Parkinson's disease;Relevanz der Plasmaspiegel-bestimmung des L-Dopa und 3-O-Methyldopa beim Morbus Parkinson

Aktuelle Neurologie

Volumn 25, Issue 4 SUPPL. 4, 1998, Pages

  Woitalla, D ^a  

^a ST JOSEF HOSPITAL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

3 O METHYLDOPA; ANTIPARKINSON AGENT; DRUG METABOLITE; LEVODOPA;

CONFERENCE PAPER; DEGENERATIVE DISEASE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG METABOLISM; HUMAN; NEUROLOGIC DISEASE; PARKINSON DISEASE; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 0032444215     PISSN: 03024350     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Eriksson, T., A. K. Granerus, A. Linde et al.: "On-Off" Phenomenon in Parkinson's Disease: Relationship between dopa and other large neutral amino acids in plasma. Neurol. 38 (1988) 1245-1248
2. Hardie, R. J., A. J. Lees, G. M. Stern: On-off fluctuations in Parkinson's disease. Brain 107 (1984) 487-506
3. Hardie, R. J., A. J. Lees, G. M. Stern: Pharmacokinetics of Levodopa and motor fluctuations. Adv. Neurol. 45 (1986) 487-492
4. Jörg, J., I. Schneider: Zur Klinik und Pathogenese des "on-off"-Phänomens beim Parkinson-Syndrom. Fortschr. Neurol. Psychiat. 56 (1988) 22-34
5. Lees, A.: The on-off phenomenon. J. Neurol. Neurosurg. Psych. Sp. Suppl. (1989) 29-37
6. Luquin, M. R., J. Vaamonde, J. A. Obeso: Levodopa and 3-O-Methyldopa plasma levels in Parkinsonian patients with stable and fluctuating motor response. Clin. Neuropharm. 12 N4 (1989) 46-54
7. Nutt, J. G., W. R. Woodward: Levodopa pharmakokinetics and pharmakodynamics in fluctuating Parkinsonian patients. Neurol. 36 (1986) 739-44
8. Poewe, W. H.: Clinical aspects of motor fluctuations in Parkinson's disease. Neurol. 44, Suppl. 6 (1994) S6-9